Latest Market Share News

Aspermont Limited reports a 7% revenue increase driven by subscription growth and a landmark contract with a top global mining company, while preparing to launch new data products.

Central Petroleum Limited has announced an on-market share buy-back program of up to 10% of its issued shares, supported by robust cash flows from new multi-year gas sale contracts and existing reserves.

NGX Limited progresses its Malingunde graphite project with technical studies and stakeholder engagement, while uranium exploration permits advance in Namibia. The company stands to benefit from new US anti-dumping tariffs on Chinese graphite imports.

BluGlass Limited has secured its first order from the Indian Department of Defence and reported a significant 16% improvement in visible laser efficiency, alongside raising $7.6 million to support growth.

Experience Co Limited has reported unaudited FY25 results showing solid revenue and underlying EBITDA growth, driven by strong demand in skydiving and adventure experiences despite some weather-related setbacks.

Rand Mining Ltd reported solid gold production of 8,916 ounces in the June 2025 quarter, alongside improved cash flow and ongoing exploration success at key Western Australian projects.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 alongside continued cash flow improvements.

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Wisr has reported a robust Q4FY25 with a 154% surge in loan originations and a growing loan book now at $824 million, underpinned by improved credit metrics and strong capitalisation.

PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.

Pureprofile Limited reported record FY25 results, achieving 19% revenue growth and launching new AI-driven data solutions to fuel future expansion.